Orforglipron providers, compare all-in monthly price
The first non-peptide oral GLP-1 pill (FDA-approved April 2026, sold as Foundayo). No injections and no refrigeration, available cash-pay direct from the manufacturer.
Cheapest Orforglipron
verified Aug 1, 2026Compounded
Not published
Not published
Brands containing orforglipron: Foundayo.
Foundayo cash-pay price, by dose
Foundayo (orforglipron) is priced by dose: the sample all-in cost rises as your dose increases. These are sample, timestamped figures, confirm current terms at checkout on the provider's site.
- Starting dose$149/mo
- Mid dose$249/mo
- Higher dose$349/mo
Sample data via LillyDirect, pending checkout re-verification. A manufacturer savings card may lower the price.
Every price read from the provider's own page and linked to its source, most recently Aug 1, 2026. On 8 of 30 listings the provider doesn't publish enough to know the real monthly cost, so we say so rather than guess. Prices change often; confirm at checkout before buying. How we verify.
Showing 1 of 1 offers · lowest all-in monthly price first
Orforglipron · oral
Foundayo (orforglipron) oral pill, advertised by Lilly as "starting at $149" through LillyDirect self-pay. Higher dose tiers cost more and the full ladder is not published on the LillyDirect landing page.
What's in this $149
- Medication
- Membership fee included
- Shipping included
- Consult required
Visit site$149/moall-in monthly
Not sure whether to choose a compounded or an FDA-approved option? Read our compounded vs FDA-approved guide →
Common questions
What is orforglipron?
Orforglipron is a non-peptide oral GLP-1 medication made by Eli Lilly and sold under the brand name Foundayo. It is taken as a once-daily pill, requires no injections, and does not need refrigeration. It received FDA approval in April 2026 and requires a prescription.
How much does Foundayo cost?
Foundayo (orforglipron) is priced by dose, sold cash-pay direct from Eli Lilly through LillyDirect. In our source-verified pricing, the lowest dose starts at roughly $149 a month and the cost rises to about $349 a month at higher doses. These prices are read from the provider's own site and timestamped, and are not a guarantee; confirm current terms at checkout on the provider's site.
Is orforglipron the same as Ozempic or semaglutide?
No. Orforglipron and semaglutide are different molecules. Semaglutide is the GLP-1 in Ozempic and Wegovy, made by Novo Nordisk. Orforglipron is a separate, non-peptide GLP-1 made by Eli Lilly and sold as Foundayo. They are not interchangeable and are not the same drug.
Is Foundayo a pill?
Yes. Foundayo (orforglipron) is a once-daily oral pill. It is a non-peptide oral GLP-1, so it does not require injections and does not need to be refrigerated, unlike injectable GLP-1 options such as Wegovy and Zepbound.
Is orforglipron FDA-approved?
Yes. Orforglipron, sold as Foundayo by Eli Lilly, received FDA approval in April 2026. It is a prescription medication available cash-pay direct from the manufacturer. This differs from compounded GLP-1 products, which are not FDA-approved.
Foundayo vs the Wegovy pill: what is the difference?
Foundayo (orforglipron) and the oral Wegovy pill are both daily oral GLP-1 medications, but they use different molecules from different makers: orforglipron from Eli Lilly and semaglutide from Novo Nordisk. See our Foundayo vs Wegovy comparison for sample pricing, forms, and regulatory status side by side.